Experience of contamination during autologous cell manufacturing in cell processing facility under the Japanese Medical Practitioners Act and the Medical Care Act-Reference-Cited by-同舟云学术

Experience of contamination during autologous cell manufacturing in cell processing facility under the Japanese Medical Practitioners Act and the Medical Care Act

Published:2016-12 Issue: Volume:5 Page:25-30
ISSN:2352-3204
Container-title:Regenerative Therapy
language:en
Short-container-title:Regenerative Therapy

Author:

Mizutani Manabu^ORCID,Samejima Hazuki,Terunuma Hiroshi,Kino-oka Masahiro

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Developmental Biology,Biomedical Engineering,Biomaterials

Reference12 articles.

1. New governmental regulatory system for stem cell-based therapies in Japan;Hara;Ther Innov Regul Sci,2014

2. New Japanese initiatives on stem cell therapies;Konomi;Cell Stem Cell,2015

3. Consideration of and expectations for the pharmaceuticals, medical devices and other therapeutic products act in Japan;Okada;Regen Ther,2015

4. Guideline no. 24, guideline for changeover of autologous cell-based manufacturing;[in Japanese];Minist Econ Trade Ind,2015

5. Synergistic cytotoxicity of ex vivo expanded natural killer cells in combination with monoclonal antibody drugs against cancer cells;Deng;Int Immunopharmacol,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbes identified from monitoring cell manipulations in 5-year life of the Cell Factory G. Gaslini;Regenerative Therapy;2024-12

2. Operator-derived particles and falling bacteria in biosafety cabinets;Regenerative Therapy;2024-03

3. Volatile organic compounds and ionic substances contamination in cell processing facilities during rest period; a preliminary assessment of exposure to cell processing operators;Regenerative Therapy;2023-12

4. Assessment of microbial contamination in laser materials processing laboratories used for prototyping of biomedical devices;Access Microbiology;2023-12-01

5. Effect of disinfectants and manual wiping for processing the cell product changeover in a biosafety cabinet;Regenerative Therapy;2023-03